Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07529756 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry

Study acronym: CALIBER
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment increased: 87 → 500 participants
    • Start date: Jun 2026 to Aug 2026
    v4
  2. Interventions: mechanical thrombectomy (Device) to Recanalization and debulking (Device)v3
  3. Enrollment target: 86 to 87
    • Secondary endpoints: details revised at 1 of 10 entries
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to gather additional safety and performance (effectiveness) data on the device for the treatment of symptomatic lower extremity venous obstructions and occlusions. The main questions the study aims to answer are: * What is the observed rate of safety events through the 30-day follow-up? * What is the rate of technical success (acute procedural success) achieved at the index procedure? Participants already undergoing treatment with the Recana as part of their regular medical care will be followed for 1 year.
Trial Details
NCT Number NCT07529756
Lead Sponsor Intervene, Inc.
Conditions
(from sponsor)		 Chronic Venous Disease, Chronic Venous Insufficiency, CVI, Venous Thrombosis, Thrombosis (Stent Thrombosis), Thrombosis, Venous, Embolism and Thrombosis, Thrombectomy
Related terms Bites and Stings, Blindness, Cortical, Embolism, Embolism and Thrombosis, Thrombosis, Venous Thrombosis
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov